| http://www.w3.org/ns/prov#value | - group and to AZT control group].11:50 [Regarding outcome of above HIV study] We did extremely well.12:00 [NanoViricides drug pipeline in development and in testing: Influenza-A, External viral diseases of the eye including Herpes and Adenovirus, HIV AIDS, Dengue, Rabies, Ebola, Marburg, and ability to rapidly create new drug in the field in response to novel infection or viral bioterrorist attac
|
